ArticleCureus2025
Incidence and Pattern of Hypertensive Disorders of Pregnancy in Akwa Ibom and Cross River States, Nigeria.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHypertensive disorders of pregnancy (HDP) are the leading cause of maternal and perinatal morbidity and mortality in developing countries. The incidence and pattern of these disorders are not known in most of these countries. Hence, the need to determine the incidence and pattern of these disorders in Akwa Ibom State (AKS) and Cross River State (CRS) of Nigeria.
methodsIn a prospective cohort study, all pregnant women who presented at the booking clinics of the referral level hospitals in AKS and CRS over a ten-month period (February 2023 to November 2023) were screened. Those with a confirmed gestational age of ≤20 weeks, whether hypertensive or normotensive, who gave their informed consent were recruited for the study and followed up till delivery. Data collected included age, parity, gestational age at enrollment, educational status, and marital status. Booking Blood pressure, weight, and height were measured, and qualitative urine protein status was also obtained for each participant. The data obtained were analyzed using STATA (version 16, StataCorp, TX, USA).
resultsOf the 1,006 participants that were followed up till delivery in this study, 25 had chronic hypertension, 240 had pre-eclampsia, and 24 had gestational hypertension. Those married were 967/1,006 (96.1%) and 447/1,006 (44.4%) were in private businesses. The majority of them had up to secondary 322/1,006 (32%) or tertiary 652/1,006 (64.8%) level of education. The period prevalence of HDP in the study population was 28.7% (289/1,006) and 2.5% (25/1,006) for chronic hypertension. The incidence of HDP was 26.9% (264/981); 24.5% (240/981) for pre-eclampsia and 2.4% (24/981) for gestational hypertension in the study population. The patterns of HDP were 2.5% (25/1,006) for chronic hypertension; 23.9% (240/1,006) for pre-eclampsia; and 2.4% 24/1,006) for gestational hypertension in the study population.
conclusionThe incidence and prevalence of HDP in both AKS and CRS are high. Pre-eclampsia is the most common form of HDP in these states. There is a need for thorough screening for HDP in our antenatal clinics, identification of risk factors, and implementation of strategies to improve the outcomes of HDP in these states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.